"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

Clinical trial NCT03538717 · COMPLETED

Trial details

NCT number: NCT03538717
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2018-04-19
Primary completion: 2019-03-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.